Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C19orf66 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IFITM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFITM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DDX58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX60L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OAS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFI27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFI44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFI6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM69 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLKL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFITM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on